Podcasts about blood cancer

Right Thinking with Steve Coplon.This week's show is called "450 Thole Street".  Tune in and hear Steve as he invites you to travel with him back to his first neighborhood where it all really began for him. This prequel to his autobiography "The Value of a Dollar: My Memoirs and How I Learned the Work Ethic", offers insights into understanding how Steve grew up to be the man that he is. Take a look into Steve's life, take a look into your own. There's always more to learn.In this episode, I delve into my childhood memories, specifically my first neighborhood, Thole Street, as a prelude to my autobiography, "The Value of a Dollar." I share personal stories that reveal how my early experiences shaped my identity and relationships. With a focus on family dynamics, I discuss the complexities of growing up amidst confusion and conflict while highlighting the importance of understanding our roots for personal growth.Through anecdotes about neighbors and friendships, I illustrate how these formative experiences fostered resilience and community support. I stress the significance of reflection and forgiveness, encouraging listeners to evaluate their pasts and the lessons learned along the way. By the end, I hope to inspire a journey of self-discovery, urging everyone to reconnect with their memories to better understand their present selves. Join me next week as we continue this exploration of identity and growth.https://www.talknetworkradio.com/hosts/right-thinking

Dr. Anders Kolb on Leading Blood Cancer United Into a New Era by Managed Care Cast

According to Blood Cancer United (formerly the Leukemia & Lymphoma Society), approximately every 3 minutes, 1 person in the United States is diagnosed with leukemia, lymphoma, or myeloma. AML is a heterogeneous hematologic malignancy; despite advances in treatment, AML remains challenging to cure. Integrating new treatment options for patients with refractory acute myeloid leukemia (AML), including menin inhibitors, into routine oncology care can help bring novel therapies to patients with relapsed or refractory AML. ACCC is committed to providing information on the latest research and treatment options for blood cancer. In this episode, CANCER BUZZ speaks with Keri Halsema, NP, MSN, RN, nurse practitioner in the Blood Disorders Center at the University of Colorado Anschutz about the factors that influence treatment choices and the use of menin inhibitors to treat relapsed or refractory AML.   “We, as clinicians, are really excited that we have another treatment choice with respect to targeted therapy in these patients that have either the KMT2A rearrangement or the NPM1 mutation…Having outreach and making sure that community oncologists are aware that these medications are available, that various academic centers have various clinical trials that patients may qualify for and may be enrolled in, that's something that's very important in moving care forward for these patients with AML.” – Keri Halsema, NP, MSN, RN   Keri Halsema, NP, MSN, RN Nurse Practitioner Blood Disorders Center University of Colorado Anschutz Aurora, CO   Resources: Menin Matters   ACCC Hematologic Malignancies   ACCC AML Resource Page   ACCC Educational Video: Best Practices and Solutions for Performing Bone Marrow Biopsies in AML Care   Leukemia & Lymphoma Society Facts and Statistics   Menin inhibitors in the treatment of acute myeloid leukemia

Light the Night 2025 with Blood Cancer United (formerly Leukemia & Lymphoma Society)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Right Thinking with Steve Coplon | Guest: Henry SmithThis week's show is called "A Smashing Success" with guest Henry Smith. Tune in and hear Steve interview Henry, a young, budding entrepreneur, and know why Steve firmly believes that the future is safe with rising stars like Henry securing the future. You will be captivated when you hear what Henry is doing with his life and how he got there.In "A Smashing Success," Steve Copelan interviews Henry Smith, a 21-year-old entrepreneur and founder of the burger restaurant Smashers. Henry shares his journey from experimenting with burger recipes during the COVID-19 pandemic to launching a successful food truck and restaurant.The discussion emphasizes financial literacy for youth, highlighting Henry's plans to incorporate educational initiatives into his business. They also explore themes of work ethic, mentorship, and community service, advocating for the skills and potential of younger generations. The episode concludes with an optimistic outlook on the impact of young leaders like Henry.https://www.talknetworkradio.com/hosts/right-thinking

In this week's Talking Health, Jessica is joined by Dr Juho Jalkanen – Chief Executive Officer at Faron Pharmaceuticals, to discuss the clinical trials of bexmarilimab for blood cancer treatment.

13th Annual Bachelor Auction for Blood Cancer benefiting Blood Cancer United (formerly Leukemia & Lymphoma Society)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

There are calls for the government to settle an unpaid debt, a promise made by National to blood cancer sufferers, desperate for access to drugs not funded in Aotearoa. On the election campaign, National pledged to fund a list of medications for solid cancer tumours. It was forced to make good on that, following public backlash over a lack of action. But it had also given assurances about closing the medicine gap for blood cancer patients too, yet two years on they're still dying for it to deliver.

Prior to the election, Christopher Luxon made a commitment to fund a list of hard tumour cancer medications. At the same time National repeatedly promised that blood cancer sufferers would not be forgotten. But two years on from that promise, many of them do feel forgotten. The drug Daratumumab, or Dara is on Pharmac's priority drug list. That's the list of drugs it would like to fund, but can't afford. Dara is virtually free in Australia, but costs hundreds of thousand of dollars here. That means some desperate blood cancer patients are funding it themselves; relying on the kindness of others and donation pages. Aucklander Geoff Dawson, has multiple Myeloma, and is on Dara, he spoke to Lisa Owen.

Right Thinking with Steve Coplon.This week's show is called "Having Something in Your Back Pocket." Tune in and hear Steve talk about how having something to fall back on will help you keep the good fight going.https://www.talknetworkradio.com/hosts/right-thinking

At the Society of Hematologic Oncology 2025 Annual Meeting, CancerNetwork® spoke with a variety of experts about notable clinical developments and trial results across the hematologic oncology landscape. Throughout the meeting, clinicians and researchers discussed the latest data and initiatives in myelofibrosis, multiple myeloma, lymphoma, and other types of blood cancer. Francesca Palandri, MD, PhD, an adjunct professor in the Department of Medical and Surgical Sciences at the University of Bologna in Bologna, Italy, shared insights from a session focused on exploring predictive markers for the efficacy of ruxolitinib (Jakafi) among patients with myelofibrosis.1 Noting variance in response rates as well as possibilities of disease progression or treatment discontinuation associated with ruxolitinib, Palandri emphasized the importance of assessing predictors of response to better orient clinical decision-making strategies regarding the agent's use. She also highlighted how factors such as cytopenic phenotype, higher peripheral blast counts, and higher burden of disease may impact response rates and survival among patients. Additionally, Sundar Jagannath, MD, a professor of Medicine specializing in hematology and medical oncology at the Icahn School of Medicine at Mount Sinai and The Tisch Cancer Institute, spoke about his presentation on potentially defining a cure in the management of multiple myeloma.2 He described the importance of “chang[ing] the dialogue” in multiple myeloma to give hope to patients and encourage physicians to engage in patient care more optimally. By defining a cure in multiple myeloma, Jagannath stated, it may be possible to offer more finite durations of treatment and stop therapy with the confidence that patients will not relapse. Finally, Adam J. Olszewski, MD, an associate professor of medicine at The Warren Alpert Medical School of Brown University, discussed his work on the phase 3 SUNMO trial (NCT05171647).3 Findings from this presentation showed that mosunetuzumab-axgb (Lunsumio) plus polatuzumab vedotin-piiq (Polivy; M-Pola) reduced the risk of progression or death by 59% vs rituximab (Rituxan) with gemcitabine and oxaliplatin (R-GemOx) in relapsed/refractory large B-cell lymphoma (LBCL). Olszewski also outlined next steps for refining treatment strategies in this patient population. References Palandri F. Predictive markers for ruxolitinib in MF. Presented at the Society of Hematologic Oncology 2025 Annual Meeting; September 3-6, 2025; Houston, TX. Jagannath S. Is it time to say “CURE” in multiple myeloma? Presented at the Society of Hematologic Oncology 2025 Annual Meeting; September 3-6, 2025; Houston, TX. Westin J, Zhang H, Kim W, et al. Mosunetuzumab plus polatuzumab vedotin is superior R-GemOx in transplant-ineligible patients with R/R LBCL: primary results of the phase III SUNMO trial. Presented at the Society of Hematologic Oncology 2025 Annual Meeting; September 3-6, 2025; Houston, TX. Abstract ABCL-1492.

Send us a textDr. Juho Jalkanen, M.D., Ph.D. is CEO and Founder of Faron Pharmaceuticals ( https://faron.com/ ), is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient's own immune system. The Company's lead asset bexmarilimab is currently being investigated in clinical trials as a potential therapy for patients with hematological cancers, with an initial focus on higher-risk myelodysplastic syndrome (HR MDS), in combination with other standard treatments.Dr. Jalkanen an experienced biopharmaceutical industry executive with extensive leadership experience across key functional areas including operations, business development, clinical development, medical and regulatory affairs.   Dr. Jalkanen earned a Master´s degree in economics and business administration from the Turku School of Economics and both his M.D. and Ph.D. degrees from the University of Turku. He is a fully licensed general practitioner and specialist in vascular surgery.#JuhoJalkanen #FaronPharmaceuticals #Bexmarilimab #MyelodysplasticSyndrome #HematologicalCancers #HematologicalMalignancies #BloodCancer #AcuteMyeloidLeukemia #Clever1 #Macrophages #Oncology #Immunooncology #Cancer #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this special episode of The Bloodline, we introduce our new name and what it means for blood cancer patients, […] The post We are Blood Cancer United: a new name, an unstoppable community first appeared on The Bloodline with Blood Cancer United Podcast.

Right Thinking with Steve Coplon | Guest: Jim StovallThis week's show is called "Celebrating 200" with guest Jim Stovall. Tune in and hear Steve and Jim celebrate the 200th episode of Right Thinking with Steve Coplon by discussing Jim's bestselling book Ultimate Hindsight, Wisdom from 100 Super Achievers. You will be captivated while Steve picks up valuable pointers on how to be a better radio host.https://www.talknetworkradio.com/hosts/right-thinking

The Leukaemia Foundation says one in 12 people in Australia is at risk of being diagnosed with blood cancer. Still, a lack of awareness about symptoms means many cancers go undiagnosed for longer periods. Sydney-based GP Prabin Pathak spoke to SBS Nepali about symptoms and precautionary measures people can take. This audio has been updated due to an inadvertent technical error earlier. - लुकिमिया फाउन्डेसनले अस्ट्रेलियामा १२ मध्ये एक जनालाई रक्त क्यान्सर हुने जोखिम रहेको बताउँदै गर्दा, यसका लक्षणहरू बारे जागरूकताको कमी हुँदा धेरै मानिसहरू यस्ता क्यान्सरहरू लामो समयसम्म पत्ता नलाग्ने अवस्थामा पुग्ने गरेका छन्। सेप्टेम्बर महिनालाई रगतको क्यान्सरसँग सम्बन्धित रहेर जनचेतना अभिवृद्धि गर्ने महिनाका रूपमा लिने गरिन्छ। यसै अवसरमा अस्ट्रेलियामा ‘साइलेन्ट किलर' पनि भनिने रगतसँग सम्बन्धित क्यान्सरको अवस्था र उपचारको व्यवस्था चाहिँ कस्तो छ त? रक्त क्यान्सरका लक्षण र सतर्कताका लागि अपनाउन सकिने उपायहरूका बारेमा, सिड्नीस्थित एक जीपी प्रबिन पाठकसँग, एसबीएस नेपालीले गरेको कुराकानी सुन्नुहोस्। नोट: प्राविधिक गडबडीका कारण यो पोडकास्ट पहिले प्रकाशित हुँदा अरू नै सामाग्री बजेकोमा हामी क्षमाप्रार्थी छौँ।

See omnystudio.com/listener for privacy information.

It's been 24 years since the 9/11 terror attacks. The unity that once brought us together has faded, but each year we honor the anniversary through the 9/11 Day of Service and Remembrance. Manny speaks with Jay Winuk, Co-founder & Executive Vice President of 9/11 Day, about the importance of keeping that spirit alive.Plus, September is Blood Cancer Awareness Month. Leigh Clark, Sr. Director of Patient Programs at the Aplastic Anemia and MDS International Foundation, joins the conversation to share insights and resources for patients and families.

Join Zafer Ahmad and Usman Ali for Thursday's show from 4-6pm where we will be discussing: ‘Blood Cancer' and 'AI Psychosis'. Blood Cancer Blood cancer comes in three major forms — leukaemia, lymphoma, and myeloma — each affecting the body in different ways. Knowing the signs and symptoms can save lives, making early detection critical. Advances in treatment and research offer hope, while prevention and support remain essential in the fight against these diseases. AI Psychosis From casual chats to marriages, AI chatbots are becoming more than just tools — but experts warn of “AI psychosis” and growing dependence. With AI's endless agreeableness, walking away can be harder than quitting social media or other addictions. Are we embracing innovation — or replacing real human connection with something that cannot truly love us back? Join us as we explore the rise — and risks — of AI relationships. Guests: Gemma Trout - Senior nurse in blood cancer organisation Tasneen Ali -  GP and DKMS Volunteer Hub Lead in Leicester Dr. Sophie Castell -  Co-Chair of the Blood Cancer Alliance and CEO of Myeloma UK Rhys Owens  -  Senior clinical Practice officer at Myeloma UK Producers Azka Hina and Zohra Mobashir

In this episode, host Jonathan Sackier is joined by Andrew Dunbar, Assistant Professor in the Department of Hematopoietic Biology and Malignancy at the University of Texas MD Anderson Cancer Center, Houston, USA. Dunbar discusses his research into myeloproliferative neoplasms, what drives disease progression and resistance, and promising targets for treatment, while reflecting on the mission of his lab and what lies ahead for the field.  Timestamps  00:00 – Introduction  02:29 – One thing people should know about myeloproliferative neoplasms  05:01 – Dunbar's background and research focus  08:00 – What would Dunbar do if not science and medicine?  10:24 – The basics of myeloproliferative neoplasms  14:30 – Myeloproliferative neoplasm diagnosis and treatment  16:49 – What drives disease progression and resistance?  18:30 – The mission of Dunbar's lab  21:23 – Development of AJ1-11095  22:54 – Balancing the complexity of disease modelling with urgent clinical needs  24:03 – Promising targets and pathways  26:35 – What's on the horizon?  28:40 – Three wishes 

Right Thinking with Steve Coplon | Guest: Donna CoplonThis week's show is called "Do Not Become Weary" with guest Donna Coplon. Tune in and hear Donna and Steve talk about the journey they have shared together, offering words of encouragement on how to persevere and keep believing when life isn't always easy.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon | Guest: Robin CasarjianThis week's show called "Making Time Count with Robin Casarjian."  Tune in and hear Steve and Robin have a beautiful conversation with Barbara Jean Crehan as they talk about Robin's nationally acclaimed program Making Time Count. Your heart will be touched as Robin shares words of wisdom with Barbara Jean, a person who is deeply committed to making a difference with incarcerated individuals.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon | Guest: Lefford FateThis week's show is called "Everybody Speaks with Guest Lefford Fate." Tune in and hear Steve and Lefford discuss Lefford's new book that deals with the fact that everyone has a voice and should be able to freely express it. What is holding you back? This conversation will greatly help you bring your voice forth.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show called "The 5 Essential Principles  of Think  & Grow Rich, a  Passionate Recommendation." Tune in and hear Steve talk about the Napoleon Hill Foundation's newest, must-read book The 5 Essential Principles of Think & Grow Rich, the Practical Steps to Transforming Your Desires into Riches by Napoleon Hill.  Steve is honored to present profound and essential truths about the power of the mind that Napoleon Hill presented over 80 years ago in his masterpiece Think and Grow Rich.  This show will get you thinking and move you to positive steps to a better life.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show called "The Gift of Yourself." Tune in and hear Steve talk about the unique gifts and talents that we each have as he shares insights inspired by Jim Stovall and Don Green's newest book "The Gift of Giving, Living Your Legacy." You will be inspired to give more of yourself to others and experience greater personal happiness than ever before.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show called "Right Thinking Foundation – A State of the Union."  Tune in and hear Steve give a "State of the Union" message of Right Thinking's past, present and future as he explains its purpose and how the foundation is helping to change the lives of many in a positive way. Want to do something with your life? This show will help you know that you can.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show is called "If". Tune in and hear Steve speak directly to one of the main reasons why so many people fail to be successful: they make excuses instead of taking accountability. When you stop making excuses and start taking ownership for your actions, you will be way down the road towards success.In this episode of Right Thinking, I explore the barriers self-imposed excuses create on the path to success and the importance of personal accountability. Inspired by a conversation with my wife, I reflect on Matthew 7:3-5, emphasizing the hypocrisy in focusing on others' shortcomings while neglecting our own.I discuss insights from my book, "From the Lip to the Hip is a Pretty Far Distance," and highlight Napoleon Hill's concept of alibis, detailing 57 common excuses that hinder true potential. I urge listeners to confront their mental barriers and redefine their mindsets to embrace personal responsibility and proactive behavior. The episode concludes with actionable strategies for overcoming excuses and fostering a culture of self-improvement and accountability.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show is called "The Light at the End of the Tunnel." Tune in and hear Steve share thoughts on a recent road trip that has provided clarity and confirmation that the path he is traveling through life on is the right path.  This show will give hope and encouragement to all who listen.In this episode, I recount a transformative road trip titled "The Light at the End of the Tunnel" with my friend Jack. Our journey through several states sparked reflections on friendship, adventure, and personal growth. A highlight was a hike through the Blue Ridge Tunnel, symbolizing the clarity found amidst challenges.We visited the Napoleon Hill Foundation, where discussions on applied faith inspired me to emphasize the importance of belief and action. I conclude by celebrating family connections, reminding listeners that love and support guide us through life's tunnels.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show is in honor of the 4th of July and is called Reflections on Freedom. Tune in and hear Steve talk about the freedoms we enjoy in America and hear him provide encouragement to embrace our precious freedoms.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show is called "And This Too Shall Pass." Tune in and hear Steve offer words of encouragement that will help each of us maintain a healthy perspective as we go through our daily lives and experience difficult situations that make us angry and bring on stress.  God has a plan.In this episode of Right Thinking with Steve Copeland, titled "And This Too Shall Pass," I delve into maintaining a healthy perspective during life's challenges. Building on feedback from previous shows, I aim to provide encouragement through shared struggles, emphasizing the bigger plan God has for us. I reflect on my personal journey and the importance of authenticity in my mission with the Right Thinking Foundation, enhancing our understanding of joy amidst trials.I explore the phrase "this too shall pass," its historical roots, and its relevance to our lives. Through biblical insights from Matthew and Philippians, I encourage listeners to let go of worries, reconnect with spiritual priorities, and recognize the fleeting nature of struggles compared to eternal promises. I also highlight Psalm 91's call for refuge in God's love and share inspiration from the song "Waymaker." My goal is for listeners to leave with renewed faith and gratitude, recognizing that divine peace is always within reach.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show is called "Finally Surrendering." Tune in and hear Steve share important moments in his life when he knew that the obstacles that he was facing were far bigger than himself and he knew he had to surrender. This show will inspire you to do the same.In this episode of Right Thinking, I discuss the power of surrendering in challenging times and the strength found in seeking support from a higher power. I reflect on my spiritual journey, emphasizing the importance of intentionality in healing and faith. A personal experience highlights a divine encounter that brought peace amidst turmoil.I connect lessons from martial arts to spiritual clarity and stress the need to align with God's will through compassion and service. I conclude with a verse from Micah 6:8, encouraging listeners to prioritize spiritual fulfillment over material success.https://www.talknetworkradio.com/hosts/right-thinking

Right Thinking with Steve Coplon.This week's show is called "This Is Not Our Home." Please tune in and hear Steve share stories of his deep faith, which gives him the strength and courage to carry on with an attitude of thankfulness despite living with tremendous adversity. This show will help you face your hardships.In this episode, I reflect on perseverance through a deep faith that emphasizes our spiritual existence beyond the physical world. Titled "This Is Not Our Home," I share lessons learned from my friendship with Steve Thomas, whose blindness taught me to maintain a higher perspective amidst adversity.Drawing from martial arts, I highlight adaptability and the warrior mindset. Anchored in scripture, I encourage listeners to cultivate gratitude and trust in the Lord's plan, transforming challenges into opportunities for growth and resilience.https://www.talknetworkradio.com/hosts/right-thinking

Alexandra Wilson passed away just 10 months after being diagnosed with Acute Lymphoblastic Leukemia in March of 2002, from this Blood Cancer that normally has a very high cure rate. Her twin sister Arianna will talk about her sister and about her role as the now official Executive Director of the Alex's Team Foundation which was named in Alexandra's honor, and helps in many ways the cause of Pediatric Cancer, with an emphasis on the Pediatric Cancer Nursing Community. 

Rory McGowan is joined by Dr Juho Jalkanen from Faron Pharmaceuticals. In this episode they discuss a new blood cancer trial has shown highly promising results, particularly for patients who have relapsed or live with hard-to-treat forms of the disease. https://faron.com/ 

Right Thinking with Steve Coplon | Guest: Johnnie LloydThis week's show is called "Afterword – the Reunion" with guest Johnnie Lloyd. Tune in to this follow-on to Right Thinking: Life Money Relationships, and hear Steve and Johnnie reunite to discuss the immortal words of Bob Dylan's "the Times They are A-Changin'." You will be inspired to modify the way that you handle your finances as we are living in increasingly uncertain economic times. This show is guaranteed to add value to your life.https://www.talknetworkradio.com/hosts/right-thinking

It's a big day at WCCO, a whole day (6a-6p) dedicated to raising money for NMDP as they fight blood cancers and disorders and aim to create a world where every patient can receive their life-saving cell therapy. Florian Riedel manages the Four Seasons and he joins Jason to talk about the Four Seasons Package they're donating which includes 2-nights in an executive suite, daily breakfast at Mara for two and complimentary valet parking for one vehicle. Florian details some of the things he looks forward to every day working at the Four Seasons and what “executive suite experience” means at their hotel. During the second half of the hour Jason we collect bids for the Twins "Dugout Buddies" Package. Experience provides 4 tickets to a mutually-agreed upon date/game...and includes the opportunity for 2 kids to meet Twins players on the field during batting practice and pregame activities. Kids are sat in padded chairs right in front of the Twins dugout and players come and greet them as they come through for BP.

It's a big day at WCCO, a whole day (6a-6p) dedicated to raising money for NMDP as they fight blood cancers and disorders and aim to create a world where every patient can receive their life-saving cell therapy. Jason and Dan are live at NMDP and are joined by Brent Frederick from Jester Concepts and Ethan Walsh and his family . NMDP is a global nonprofit leader in cell therapy, helping save the lives of patients with blood cancers and disorders.

It's a big day at WCCO, not just Chad's birthday but its the Cure Blood Cancer Radio Auction in partnership with NMDP! Chad is joined by Todd Peterson who is the Executive Director with NMDP. Chad and Todd talk about what brought him to working with NMDP and the interactions they have with people when they reach out to the organization after being touched by blood cancer.. They take bids on the Twins Executive Balcony package where 20 ticket winners join Chad Hartman, Dave Harrigan for the Thursday, June 26th 12:10p game vs Seattle Mariners. The experience includes fully catered food & beverage from one of the coolest private viewing spots at Target Field! In the second half of the hour Chad and Dave take bids on the TPC/3M Package which includes golf/tee times for 4 at the exclusive TPC club in Blaine...PLUS, 4 tickets to the 3rd round at the 3M Open, on Saturday July 26th - which includes a concert that evening with country music recording & touring artist Lee Brice.

Chad is joined by Jordana Green to kick off the second hour at the Cure Blood Cancer Radio Auction alongside NMDP. We gather bids for the the MN United Gameday VIP Experience with Chad Hartman which includes personal “chalk talk” with Minnesota soccer legend Manny Lagos, a mini tour of Alliance Stadium before the game and the opportunity to watch warm ups from the home team bench! NMDP aims to create a world where every patient can receive their life-saving cell therapy.

It's a big day at WCCO, not just Chad's birthday but its the Cure Blood Cancer Radio Auction in partnership with NMDP! We kick the bidding items off with a dinner for two in the famous Sid Hartman booth at Murray's Steakhouse! Chad is joined by Erica Jensen (Senior Vice President, Innovation, Strategy & Marketing at NMDP. NMDP is a global nonprofit leader in cell therapy, helping save the lives of patients with blood cancers and disorders. NMDP aims to create a world where every patient can receive their life-saving cell therapy.

We talk about the discovery and its implications for millions of people.

Thursday May 22, 2025 Common Energy Drink Ingredient Linked to Blood Cancer

The Leukaemia Foundation says one in 12 people in Australia are at risk of being diagnosed with a blood cancer, but a lack of awareness about symptoms means many cancers go undiagnosed for longer periods. The Foundation says blood cancers are likely to overtake other cancers by 2035. - ल्युकेमिया फाउन्डेसनका अनुसार अस्ट्रेलियामा हरेक १२ मध्ये एक व्यक्ति ब्लड वा रगतको क्यान्सरको जोखिममा छन्। तर लक्षणबारे पर्याप्त जानकारी नहुँदा धेरैजसोमा ढिलो मात्र रोग पत्ता लाग्ने गरेको छ। सन् २०३५ सम्ममा ब्लड क्यान्सरको सङ्क्रमण अन्य क्यान्सरभन्दा धेरै हुने सम्भावना बढेको फाउन्डेसनको भनाइ छ।

Joao wants to know what happens when stem cells of our own, which have been cultivated outside the body, are reintroduced to the bloodstream. This got James Tytko thinking about autologous stem cell transplants, used as a treatment for some forms of blood cancer. He asked Tania Dexter, haematology registrar, and senior medical officer at the Anthony Nolan Institute, to help explain... Like this podcast? Please help us by supporting the Naked Scientists

The Leukaemia Foundation says one in 12 people in Australia are at risk of being diagnosed with a blood cancer, but a lack of awareness about symptoms means many cancers go undiagnosed for longer periods.The Foundation says blood cancers are likely to overtake other cancers by 2035.

Cancer can be lonely and isolating. Meet a patient who has started a special support group to help fellow cancer patients.

A simple cheek swab could mean the difference between life and death for a patient with blood cancer.

As part of the Leukemia & Lymphoma Society Visionaries of the Year fundraising campaign, I will be highlighting the humans in front of blood cancer. This week, we highlight Kristen!  To donate to our fundraising campaign, go to: https://pages.lls.org/voy/sun/sun25/ccometa To watch the full interview: https://youtu.be/IKdqGiPJjV4

As part of the Leukemia & Lymphoma Society Visionaries of the Year fundraising campaign, I will be highlighting the humans in front of blood cancer. This week, I am sharing my personal journey with my Dad! To donate to our fundraising campaign, go to: https://pages.lls.org/voy/sun/sun25/ccometa